Skip Navigation

Randomized Phase II Trial of Topotecan plus M6620 VX-970 vs. Topotecan alone in Patients with Relapsed Small-Cell Lung Cancer.

Brief Summary

Type:
Lung Cancers

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT03896503

Study #:
STUDY00146148

Start Date:
Nov 05, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03896503

View Complete Trial Details & Eligibility at ClinicalTrials.gov